Hog Prices Continue To Struggle

Forward hog contract prices continue to struggle to make any positive headway.

 

Tyler Fulton is the Director of Risk Management with Hams Marketing Services.

 

"Overwhelmingly the hog supply is putting a lot of pressure on cash markets and futures markets and so consequently the forward prices that Western Canadian hog producers can contract for are also depressed...We're dealing with lean hog futures that are the main input into a forward contract price and then you of course will convert it into Canadian dollars and consequently because the U.S. futures are under severe pressure, due to the record large hog supplies, we're seeing really not a lot of opportunity to price at better levels than what we saw five or six months ago."

 

Fulton notes the main issue right now is the cash hog market and how many hogs there are, adding it's putting a lot of pressure on at a time when we would typically be hoping to see increased flow and increased positive price influence coming from the increased exports.

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.